Citius Pharmaceuticals, Inc. Proceeds from Notes Payable
Citius Pharmaceuticals, Inc. (CTXR) reported Proceeds from Notes Payable of $1.30 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-23.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-12-23
- Citius Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2025-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2021-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2021-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2021-03-31 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2025 was $1.30M.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2021 was $500.00, a 99.70% decline from fiscal 2020.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2020 was $164.58K.
- Citius Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2016 was $500.00K.
| Period end | Proceeds from Notes Payable | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $1.30M 10-K · filed 2025-12-23 | |||
| 2025-06-30 | $1.30M 10-Q · filed 2025-08-12 | ||||
| 2025-05-28 | $300.00K 10-K · filed 2025-12-23 | ||||
| 2023-05-08 | $15.00M 10-K · filed 2023-12-29 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | $0.00 derived: sum of 2 quarters · filed 2021-12-15 | $0.00 derived: sum of 3 quarters · filed 2021-12-15 | $500.00 10-K · filed 2021-12-15 | |
| 2021-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | $500.00 10-Q · filed 2021-08-12 | $500.00 derived: sum of 4 quarters · filed 2021-08-12 | |
| 2021-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | $500.00 10-Q · filed 2021-05-13 | $500.00 derived: sum of 3 quarters · filed 2021-05-13 | ||
| 2020-12-31 | $500.00 10-Q · filed 2021-02-11 | $500.00 derived: sum of 2 quarters · filed 2021-02-11 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | $164.58K 10-K · filed 2020-12-16 | |||
| 2020-06-30 | $164.58K 10-Q · filed 2020-08-14 | ||||
| 2016-12-31 | $820.00K 10-Q · filed 2017-02-14 | ||||
| 2016-09-30 | $500.00K 10-K · filed 2016-12-23 | ||||
| 2012-09-30 | $17.05K 10-Q · filed 2013-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |